An Association of Lower Serum Citrulline Levels Within 30 Days of Acute Rejection in Patients Following Small Intestine Transplantation

A. I. David, Jeffrey Gaynor, P. P. Zis, L. Conanan, L. Goldsmith, V. Esquenazi, Gennaro Selvaggi, D. Weppler, Seigo Nishida, J. Moon, J. R. Madariaga, Phillip Ruiz, T. Kato, D. M. Levi, G. Kleiner, P. Tryphonopoulos, A. G. Tzakis

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Introduction: In a prospective protocol we studied whether serum citrulline level within 30 days of an acute rejection was predictive of the episode. Methods: An acute rejection episode was defined as the date of occurrence of any biopsy-proven rejection in which treatment was initiated until two successive biopsies showed no further rejection. We compared the mean citrulline level based on values determined within 30 days of the start of an acute rejection episode with the mean citrulline level measured on the same patient during a rejection-free period. Serum citrulline measurements were available immediately prior to the occurrence of rejection for 22 patients who experienced 37 episodes. Results: For the 12 episodes of mild rejection, the mean serum citrulline level ± SE (standard error) was 15.0 + 2.3 umol/L prior to rejection and 18.8 ± 2.4 umol/L during the rejection-free periods. A paired t test of the mean differences was not significant (P = 17). For the 25 episodes of moderate or severe rejection, the mean serum citrulline level was 12.4 ± 1.1 umol/L before rejection and 18.8 ± 2.0 umol/L during the rejection-free periods. A paired t test of the mean difference was statistically significant (P = .002). Conclusions: Although further study of citrulline as a marker for the early detection of acute rejection episodes is needed, our hope is that its use will help to prevent some of these early episodes from evolving into full-blown moderate or severe grades of rejection.

Original languageEnglish
Pages (from-to)1731-1732
Number of pages2
JournalTransplantation Proceedings
Volume38
Issue number6
DOIs
StatePublished - Jul 1 2006

Fingerprint

Citrulline
Small Intestine
Transplantation
Serum
Biopsy

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

An Association of Lower Serum Citrulline Levels Within 30 Days of Acute Rejection in Patients Following Small Intestine Transplantation. / David, A. I.; Gaynor, Jeffrey; Zis, P. P.; Conanan, L.; Goldsmith, L.; Esquenazi, V.; Selvaggi, Gennaro; Weppler, D.; Nishida, Seigo; Moon, J.; Madariaga, J. R.; Ruiz, Phillip; Kato, T.; Levi, D. M.; Kleiner, G.; Tryphonopoulos, P.; Tzakis, A. G.

In: Transplantation Proceedings, Vol. 38, No. 6, 01.07.2006, p. 1731-1732.

Research output: Contribution to journalArticle

David, AI, Gaynor, J, Zis, PP, Conanan, L, Goldsmith, L, Esquenazi, V, Selvaggi, G, Weppler, D, Nishida, S, Moon, J, Madariaga, JR, Ruiz, P, Kato, T, Levi, DM, Kleiner, G, Tryphonopoulos, P & Tzakis, AG 2006, 'An Association of Lower Serum Citrulline Levels Within 30 Days of Acute Rejection in Patients Following Small Intestine Transplantation', Transplantation Proceedings, vol. 38, no. 6, pp. 1731-1732. https://doi.org/10.1016/j.transproceed.2006.05.016
David, A. I. ; Gaynor, Jeffrey ; Zis, P. P. ; Conanan, L. ; Goldsmith, L. ; Esquenazi, V. ; Selvaggi, Gennaro ; Weppler, D. ; Nishida, Seigo ; Moon, J. ; Madariaga, J. R. ; Ruiz, Phillip ; Kato, T. ; Levi, D. M. ; Kleiner, G. ; Tryphonopoulos, P. ; Tzakis, A. G. / An Association of Lower Serum Citrulline Levels Within 30 Days of Acute Rejection in Patients Following Small Intestine Transplantation. In: Transplantation Proceedings. 2006 ; Vol. 38, No. 6. pp. 1731-1732.
@article{d7610fb68eef466585f175bac45ea541,
title = "An Association of Lower Serum Citrulline Levels Within 30 Days of Acute Rejection in Patients Following Small Intestine Transplantation",
abstract = "Introduction: In a prospective protocol we studied whether serum citrulline level within 30 days of an acute rejection was predictive of the episode. Methods: An acute rejection episode was defined as the date of occurrence of any biopsy-proven rejection in which treatment was initiated until two successive biopsies showed no further rejection. We compared the mean citrulline level based on values determined within 30 days of the start of an acute rejection episode with the mean citrulline level measured on the same patient during a rejection-free period. Serum citrulline measurements were available immediately prior to the occurrence of rejection for 22 patients who experienced 37 episodes. Results: For the 12 episodes of mild rejection, the mean serum citrulline level ± SE (standard error) was 15.0 + 2.3 umol/L prior to rejection and 18.8 ± 2.4 umol/L during the rejection-free periods. A paired t test of the mean differences was not significant (P = 17). For the 25 episodes of moderate or severe rejection, the mean serum citrulline level was 12.4 ± 1.1 umol/L before rejection and 18.8 ± 2.0 umol/L during the rejection-free periods. A paired t test of the mean difference was statistically significant (P = .002). Conclusions: Although further study of citrulline as a marker for the early detection of acute rejection episodes is needed, our hope is that its use will help to prevent some of these early episodes from evolving into full-blown moderate or severe grades of rejection.",
author = "David, {A. I.} and Jeffrey Gaynor and Zis, {P. P.} and L. Conanan and L. Goldsmith and V. Esquenazi and Gennaro Selvaggi and D. Weppler and Seigo Nishida and J. Moon and Madariaga, {J. R.} and Phillip Ruiz and T. Kato and Levi, {D. M.} and G. Kleiner and P. Tryphonopoulos and Tzakis, {A. G.}",
year = "2006",
month = "7",
day = "1",
doi = "10.1016/j.transproceed.2006.05.016",
language = "English",
volume = "38",
pages = "1731--1732",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - An Association of Lower Serum Citrulline Levels Within 30 Days of Acute Rejection in Patients Following Small Intestine Transplantation

AU - David, A. I.

AU - Gaynor, Jeffrey

AU - Zis, P. P.

AU - Conanan, L.

AU - Goldsmith, L.

AU - Esquenazi, V.

AU - Selvaggi, Gennaro

AU - Weppler, D.

AU - Nishida, Seigo

AU - Moon, J.

AU - Madariaga, J. R.

AU - Ruiz, Phillip

AU - Kato, T.

AU - Levi, D. M.

AU - Kleiner, G.

AU - Tryphonopoulos, P.

AU - Tzakis, A. G.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Introduction: In a prospective protocol we studied whether serum citrulline level within 30 days of an acute rejection was predictive of the episode. Methods: An acute rejection episode was defined as the date of occurrence of any biopsy-proven rejection in which treatment was initiated until two successive biopsies showed no further rejection. We compared the mean citrulline level based on values determined within 30 days of the start of an acute rejection episode with the mean citrulline level measured on the same patient during a rejection-free period. Serum citrulline measurements were available immediately prior to the occurrence of rejection for 22 patients who experienced 37 episodes. Results: For the 12 episodes of mild rejection, the mean serum citrulline level ± SE (standard error) was 15.0 + 2.3 umol/L prior to rejection and 18.8 ± 2.4 umol/L during the rejection-free periods. A paired t test of the mean differences was not significant (P = 17). For the 25 episodes of moderate or severe rejection, the mean serum citrulline level was 12.4 ± 1.1 umol/L before rejection and 18.8 ± 2.0 umol/L during the rejection-free periods. A paired t test of the mean difference was statistically significant (P = .002). Conclusions: Although further study of citrulline as a marker for the early detection of acute rejection episodes is needed, our hope is that its use will help to prevent some of these early episodes from evolving into full-blown moderate or severe grades of rejection.

AB - Introduction: In a prospective protocol we studied whether serum citrulline level within 30 days of an acute rejection was predictive of the episode. Methods: An acute rejection episode was defined as the date of occurrence of any biopsy-proven rejection in which treatment was initiated until two successive biopsies showed no further rejection. We compared the mean citrulline level based on values determined within 30 days of the start of an acute rejection episode with the mean citrulline level measured on the same patient during a rejection-free period. Serum citrulline measurements were available immediately prior to the occurrence of rejection for 22 patients who experienced 37 episodes. Results: For the 12 episodes of mild rejection, the mean serum citrulline level ± SE (standard error) was 15.0 + 2.3 umol/L prior to rejection and 18.8 ± 2.4 umol/L during the rejection-free periods. A paired t test of the mean differences was not significant (P = 17). For the 25 episodes of moderate or severe rejection, the mean serum citrulline level was 12.4 ± 1.1 umol/L before rejection and 18.8 ± 2.0 umol/L during the rejection-free periods. A paired t test of the mean difference was statistically significant (P = .002). Conclusions: Although further study of citrulline as a marker for the early detection of acute rejection episodes is needed, our hope is that its use will help to prevent some of these early episodes from evolving into full-blown moderate or severe grades of rejection.

UR - http://www.scopus.com/inward/record.url?scp=33746887001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746887001&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2006.05.016

DO - 10.1016/j.transproceed.2006.05.016

M3 - Article

C2 - 16908264

AN - SCOPUS:33746887001

VL - 38

SP - 1731

EP - 1732

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 6

ER -